The EIC Accelerator is a strong fit for this pre-seed AI/biotech venture, offering non-dilutive funding up to €2.5M and supporting deep tech innovations. The venture's validated proof-of-concept, EU location (Île-de-France), and alignment with pharma AI and drug resistance prediction match the programme's goals of bridging R&D and market deployment.